Predictions
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€44.22
07.05.12
07.05.12
€33.00
02.11.12
02.11.12
-22.42%
02.11.12
02.11.12
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€50.86
23.05.12
23.05.12
€36.00
02.10.12
02.10.12
-13.24%
02.10.12
02.10.12
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€34.30
04.07.12
04.07.12
€40.00
05.09.12
05.09.12
8.03%
05.09.12
05.09.12
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Biogen Inc.
Start price
Target price
Perf. (%)
€91.50
22.01.12
22.01.12
€100.00
23.07.12
23.07.12
29.40%
23.07.12
23.07.12
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€49.74
07.04.12
07.04.12
€55.01
05.07.12
05.07.12
11.87%
05.07.12
05.07.12
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€51.82
26.05.12
26.05.12
€40.00
29.05.12
29.05.12
-11.28%
29.05.12
29.05.12
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.20
12.04.12
12.04.12
€34.00
07.05.12
07.05.12
59.14%
07.05.12
07.05.12
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€29.65
11.10.11
11.10.11
€38.00
11.04.12
11.04.12
-6.99%
11.04.12
11.04.12
Abbott Laboratories
Start price
Target price
Perf. (%)
€34.75
21.08.11
21.08.11
€37.00
13.02.12
13.02.12
22.72%
13.02.12
13.02.12
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.59
15.10.11
15.10.11
€18.65
01.02.12
01.02.12
27.94%
01.02.12
01.02.12
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.68
27.07.11
27.07.11
€18.00
26.01.12
26.01.12
25.99%
26.01.12
26.01.12
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Johnson & Johnson
Start price
Target price
Perf. (%)
€45.88
30.06.11
30.06.11
€60.00
30.12.11
30.12.11
12.28%
30.12.11
30.12.11
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€29.35
17.10.11
17.10.11
€35.00
25.10.11
25.10.11
7.02%
25.10.11
25.10.11